查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2127891

自適應深部腦部刺激系統市場規模、佔有率、成長率、全球產業分析、區域趨勢及2026年至2034年預測

Adaptive Deep Brain Stimulation Systems Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 2-3個工作天內

價格

自適應深部腦部刺激系統的市場成長要素

2025年全球自適應深部腦部刺激（DMA）市場規模為5,500萬美元，預計將從2026年的9,300萬美元成長至2034年的8.447億美元，預測期內複合年成長率（CAGR）為31.8%。北美市場在全球佔領先地位，預計到2025年將佔55.09%的市場佔有率，這主要得益於其先進的醫療基礎設施、神經調控技術的高普及率以及對神經科學研究不斷成長的投資。

自適應深部腦部刺激（aDBS）系統是一種新一代神經調控技術，它能夠持續監測腦部活動，並根據患者的神經訊號自動調節電刺激強度。這些系統主要用於治療帕金森氏症、原發性顫抖、癲癇和其他運動障礙。與傳統深部腦部刺激相比，自適應系統能夠根據即時腦部活動提供個人化治療，從而在提高療效的同時最大限度地減少副作用。神經系統疾病的日益普遍、人口老化、個人化醫療意識的增強以及技術的快速創新，都在推動市場擴張。

市場趨勢

推動自適應深部腦部刺激（DBS）系統市場發展的最重要趨勢之一是將智慧編程軟體與神經刺激設備的感測功能結合。現代自適應DBS設備利用局部場電位和基於人工智慧（AI）的演算法來監測神經活動，並根據患者不斷變化的神經狀態自動調整刺激參數。這種個人化的治療方法能夠改善症狀控制，減少不必要的刺激，並提升患者的整體療效。

此外，製造商正致力於無線編程功能、基於雲端的監控平台、改進的電池技術以及臨床醫生的便利軟體介面。這些創新簡化了設備編程，同時使神經科醫生能夠為運動障礙患者提供高度個人化的治療方案。

市場促進因素

神經系統疾病盛行率的不斷上升仍然是市場成長的主要驅動力。由於人口老化和診斷率的提高，帕金森氏症、癲癇和原發性顫抖等疾病在全球範圍內持續增加。近期醫學統計數據顯示，全球數百萬患者需要長期神經系統疾病管理，使得對先進神經調控療法的需求強勁。

對神經科學研究投入的增加、臨床研究的拓展以及監管部門的積極核准，正進一步推動產品商業化。領先的製造商持續加大研發投入，致力於推出能夠透過即時刺激調節提供更佳治療效果的新一代自適應系統。

市場限制因素

儘管發展前景廣闊，但高昂的治療費用仍然是該療法廣泛應用的主要障礙。自適應DBS療法需要昂貴的植入式脈衝產生器、先進的感測軟體、複雜的手術、長期的病患監測以及持續的設備編程。

此外，對訓練有素的神經外科醫生、專業的神經科治療中心、先進的影像技術以及全面的後續護理的需求，增加了治療的總成本。這些經濟障礙限制了治療的普及，在開發中國家，這種趨勢尤其明顯。

市場機遇

新興經濟體醫療基礎設施的快速擴張為製造商帶來了巨大的成長機會。中國、印度、巴西和一些東南亞國家正在大力投資神經科設施、專科醫院和醫療技術現代化。

政府投入增加、人們對先進神經療法的認知度提高以及專科醫療服務覆蓋範圍擴大，預計將改善患者獲得自適應DBS系統的機會。此外，臨床研究合作的加強和監管支持的強化，預計也將在預測期內創造新的商業性機會。

市場挑戰

專業神經科醫療資源匱乏仍是影響市場成長的最大挑戰之一。在許多中低收入國家，神經外科醫生、神經科醫生、先進的醫療設施以及開展適應性腦深部刺激（DBS）手術所需的保險報銷支持仍然短缺。

此外，複雜的程式要求、長期的患者監測以及相對較低的患者意識仍然限制了這些先進神經調節系統的廣泛應用。

細分分析

按組件

到2025年，植入式脈衝產生器（IPG）細分市場將成為市場主導，這主要得益於具備先進感測功能的神經刺激設備在個人化神經治療領域的應用日益廣泛。 IPG技術的持續進步和產品核可的增加將鞏固該細分市場的主導地位。

受全球植入手術數量不斷增加的推動，DBS導線和延長電纜市場預計將在預測期內保持強勁成長。

用途別

帕金森氏症患者病率高，且自適應DBS技術在臨床上越來越被接受，預計到2025年，帕金森氏症將佔最大的市場佔有率，達到94.6%。對個人化治療方案的需求不斷成長，也持續推動著這一領域的成長。

預計在預測期內，癲癇領域將經歷最快的成長，這主要得益於適應性神經刺激的研究不斷深入。

最終用戶

2025年，「醫院和門診手術中心（ASC）」細分市場佔主導地位，預計2026年將佔約80.1%的市場佔有率。神經外科手術的增加、專業神經外科團隊的出現以及先進的醫療基礎設施繼續推動醫院採用該技術。

此外，隨著對神經科服務的需求不斷成長，專科診所預計也將迎來顯著成長。

區域展望

北美地區在2025年仍是最大的區域市場，市場規模達3,030萬美元。這得歸功於其先進的醫療基礎設施、優惠的報銷政策以及對研發的大力投入。預計到2026年，美國市場規模將達到約4,420萬美元，佔全球整體銷售額的近47.5%。

歐洲是第二大市場，預計到2026年將達到4,090萬美元。強大的神經科學研究機構、有利的法規環境以及先進神經刺激技術的日益普及，持續推動該地區的成長。德國和英國仍然是主要貢獻者。

亞太地區正崛起為成長最快的區域市場之一，預計到2026年將達到370萬美元。醫療保健領域的投資增加、神經系統治療設施的擴建、臨床試驗的增加以及人們對先進療法的認知不斷提高，都在加速該地區先進療法的普及應用。預計未來幾年，中國、日本和印度的市場將穩定成長。

在拉丁美洲、中東和非洲，隨著醫療基礎設施逐步改善以及對神經系統疾病治療的投資持續增加，預計將出現溫和成長。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢
  • 市場挑戰

第4章：主要考慮因素

  • 2025年主要國家和地區主要疾病的流行情況
  • 管道分析，主要公司
  • 新產品發布，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：全球自適應深部腦部刺激系統市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：按組件分類
    • 植入式脈衝產生器（IPG）
    • DBS導線和延長線
    • 附件和輔助部件
  • 市場分析、洞察與預測：按應用領域分類
    • 帕金森氏症
    • 癲癇
    • 原發性顫抖
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院/門診手術中心
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美自適應深部腦部刺激系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲自適應深部腦部刺激系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區自適應深部腦部刺激系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲自適應深部腦部刺激系統市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：2021-2034年中東和非洲自適應深部腦部刺激系統市場分析、洞察與預測

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Medtronic
    • Newronika SpA
    • The Regents of The University of California
    • Stanford University
    • University of Toronto
    • University of Florida Health
Product Code: FBI117690

Growth Factors of adaptive deep brain stimulation systems Market

The global adaptive deep brain stimulation systems market was valued at USD 55.0 million in 2025 and is projected to grow from USD 93.0 million in 2026 to USD 844.7 million by 2034, registering a CAGR of 31.8% during the forecast period. North America dominated the global market with a 55.09% market share in 2025, supported by advanced healthcare infrastructure, high adoption of neuromodulation technologies, and increasing investments in neuroscience research.

Adaptive deep brain stimulation (aDBS) systems represent the next generation of neuromodulation technology that continuously monitors brain activity and automatically adjusts electrical stimulation based on a patient's neurological signals. These systems are primarily used for treating Parkinson's disease, essential tremor, epilepsy, and other movement disorders. Compared to conventional deep brain stimulation, adaptive systems deliver personalized therapy by responding to real-time brain activity, improving treatment effectiveness while minimizing side effects. Growing prevalence of neurological disorders, rising aging populations, increasing awareness regarding personalized therapies, and rapid technological innovations are collectively driving market expansion.

Market Trends

One of the most significant trends shaping the adaptive deep brain stimulation systems market is the integration of intelligent programming software with sensing-enabled neurostimulators. Modern adaptive DBS devices utilize local field potentials and artificial intelligence-based algorithms to monitor neural activity and automatically modify stimulation parameters according to patients' changing neurological conditions. This personalized treatment approach improves symptom management, reduces unnecessary stimulation, and enhances overall patient outcomes.

Manufacturers are also focusing on wireless programming capabilities, cloud-based monitoring platforms, improved battery technologies, and clinician-friendly software interfaces. These innovations are simplifying device programming while enabling neurologists to deliver highly customized therapies for movement disorders.

Market Drivers

The growing prevalence of neurological disorders remains the primary driver of market growth. Diseases such as Parkinson's disease, epilepsy, and essential tremor continue to increase globally due to aging populations and improved diagnosis rates. According to recent healthcare statistics, millions of patients worldwide require long-term neurological management, creating strong demand for advanced neuromodulation therapies.

Increasing investments in neuroscience research, expanding clinical studies, and favorable regulatory approvals are further supporting product commercialization. Major manufacturers continue investing heavily in research and development to introduce next-generation adaptive systems capable of delivering better therapeutic outcomes through real-time stimulation adjustments.

Market Restraints

Despite promising growth prospects, high treatment costs remain a significant challenge for widespread adoption. Adaptive DBS therapy involves expensive implantable pulse generators, sophisticated sensing software, complex surgical procedures, long-term patient monitoring, and continuous device programming.

In addition, the requirement for highly trained neurosurgeons, specialized neurological centers, advanced imaging technologies, and comprehensive follow-up care increases the total cost of treatment. These financial barriers restrict adoption, particularly in developing economies with limited reimbursement coverage.

Market Opportunities

Rapid expansion of healthcare infrastructure across emerging economies presents significant growth opportunities for manufacturers. Countries such as China, India, Brazil, and several Southeast Asian nations are investing heavily in neurological care facilities, specialized hospitals, and medical technology modernization.

Growing government investments, increasing awareness of advanced neurological therapies, and expanding access to specialist healthcare services are expected to improve patient access to adaptive DBS systems. Rising clinical research collaborations and increasing regulatory support are also expected to create new commercial opportunities during the forecast period.

Market Challenges

Limited access to specialized neurological care remains one of the biggest challenges affecting market growth. Many low- and middle-income countries continue to experience shortages of neurosurgeons, neurologists, advanced hospitals, and reimbursement support necessary for adaptive DBS procedures.

Furthermore, complex programming requirements, long-term patient monitoring, and relatively limited awareness among patients continue to restrict wider adoption of these advanced neuromodulation systems.

Segmentation Analysis

By Component

The Implantable Pulse Generator (IPG) segment dominated the market in 2025 owing to increasing adoption of advanced sensing-enabled neurostimulators for personalized neurological therapy. Continuous technological improvements in implantable pulse generators and increasing product approvals are supporting segment leadership.

The DBS Leads & Extensions segment is projected to register strong growth throughout the forecast period due to increasing implantation procedures globally.

By Application

Parkinson's disease accounted for the largest market share of 94.6% in 2025 owing to the high prevalence of the disease and increasing clinical acceptance of adaptive DBS technology. Growing demand for personalized treatment solutions continues to strengthen this segment.

The epilepsy segment is anticipated to witness the fastest growth during the forecast period as research into adaptive neurostimulation expands.

By End User

The Hospitals & Ambulatory Surgery Centers (ASCs) segment dominated the market in 2025 and is expected to hold approximately 80.1% market share in 2026. Increasing neurological surgeries, availability of specialized neurosurgical teams, and advanced healthcare infrastructure continue to support hospital-based adoption.

Specialty clinics are also expected to experience substantial growth due to rising availability of specialized neurological services.

Regional Outlook

North America remained the largest regional market in 2025, reaching USD 30.3 million, supported by advanced healthcare infrastructure, favorable reimbursement systems, and strong research investments. The U.S. market is estimated to reach approximately USD 44.2 million in 2026, representing nearly 47.5% of global revenue.

Europe represents the second-largest market and is projected to reach USD 40.9 million in 2026. Strong neuroscience research institutions, favorable regulatory environments, and growing adoption of advanced neurostimulation technologies continue supporting regional growth. Germany and the U.K. remain major contributors.

Asia Pacific is emerging as one of the fastest-growing regional markets and is expected to reach USD 3.7 million in 2026. Rising healthcare investments, expanding neurological treatment facilities, growing clinical trials, and increasing awareness of advanced therapies are accelerating regional adoption. China, Japan, and India are expected to witness steady market expansion over the coming years.

Latin America and the Middle East & Africa are expected to experience moderate growth as healthcare infrastructure gradually improves and investments in neurological treatment continue increasing.

Competitive Landscape

The adaptive deep brain stimulation systems market remains highly specialized with a limited number of technology developers and research institutions. Leading companies continue focusing on product innovation, regulatory approvals, strategic collaborations, clinical trials, and advanced sensing technologies to strengthen their market position.

Major companies operating in the market include Medtronic, Newronika S.p.A., The Regents of The University of California, Stanford University, University of Toronto, and University of Florida Health. Medtronic continues to maintain leadership through continuous product innovation, while Newronika is expanding its global presence through regulatory approvals, funding initiatives, and commercialization of closed-loop adaptive DBS technologies.

Key Industry Developments

Several important developments are accelerating innovation in the adaptive deep brain stimulation systems market. In April 2026, Medtronic launched its Adaptive Deep Brain Stimulation (aDBS) system in India, expanding access to advanced Parkinson's disease treatment. In September 2025, the company announced positive ADAPT-PD clinical trial results supporting personalized therapy. During March 2025, Newronika received CE Mark approval for its AlphaDBS closed-loop stimulation system, while in February 2025, the company successfully completed a USD 15.3 million Series B funding round. These developments demonstrate the industry's strong commitment to advancing personalized neuromodulation technologies.

Conclusion

The adaptive deep brain stimulation systems market is positioned for remarkable long-term growth as personalized neuromodulation becomes an increasingly important treatment approach for neurological disorders. Growing prevalence of Parkinson's disease, epilepsy, and movement disorders, combined with continuous technological innovation, expanding clinical research, and increasing healthcare investments, will continue driving market expansion. Although high treatment costs and limited specialist availability remain challenges, rapid advances in sensing technology, artificial intelligence integration, and expanding healthcare infrastructure across emerging economies are expected to create significant growth opportunities through 2034.

Segmentation By Component, Application, End User, and Region

By Component * Implantable Pulse Generator (IPG)

  • DBS Leads & Extensions
  • Accessories & Ancillary Components

By Application * Parkinson's Disease

  • Epilepsy
  • Essential Tremor
  • Others

By End User * Hospitals & ASCs

  • Specialty Clinics
  • Others

By Region * North America (By Component, By Application, By End User, and by Country)

    • U.S. (By Component)
    • Canada (By Component)
  • Europe (By Component, By Application, By End User, and by Country/Sub-region)
    • U.K. (By Component)
    • Germany (By Component)
    • France (By Component)
    • Italy (By Component)
    • Spain (By Component)
    • Scandinavia (By Component)
    • Rest of Europe (By Component)
  • Asia Pacific (By Component, By Application, By End User, and by Country/Sub-region)
    • China (By Component)
    • Japan (By Component)
    • India (By Component)
    • Australia (By Component)
    • Southeast Asia (By Component)
    • Rest of Asia Pacific (By Component)
  • Latin America (By Component, By Application, By End User, and by Country/Sub-region)
    • Brazil (By Component)
    • Mexico (By Component)
    • Rest of Latin America (By Component)
  • Middle East & Africa (By Component, By Application, By End User, and by Country/Sub-region)
    • GCC (By Component)
    • South Africa (By Component)
    • Rest of the Middle East & Africa (By Component)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025
  • 4.2. Pipeline Analysis, Key Players
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Adaptive Deep Brain Stimulation Systems Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Component
    • 5.1.1. Implantable Pulse Generator (IPG)
    • 5.1.2. DBS Leads & Extensions
    • 5.1.3. Accessories & Ancillary Components
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Parkinson's Disease
    • 5.2.2. Epilepsy
    • 5.2.3. Essential Tremor
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Adaptive Deep Brain Stimulation Systems Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Component
    • 6.1.1. Implantable Pulse Generator (IPG)
    • 6.1.2. DBS Leads & Extensions
    • 6.1.3. Accessories & Ancillary Components
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Parkinson's Disease
    • 6.2.2. Epilepsy
    • 6.2.3. Essential Tremor
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Component
    • 6.4.2. Canada
      • 6.4.2.1. By Component

7. Europe Adaptive Deep Brain Stimulation Systems Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Component
    • 7.1.1. Implantable Pulse Generator (IPG)
    • 7.1.2. DBS Leads & Extensions
    • 7.1.3. Accessories & Ancillary Components
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Parkinson's Disease
    • 7.2.2. Epilepsy
    • 7.2.3. Essential Tremor
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. By Component
    • 7.4.2. Germany
      • 7.4.2.1. By Component
    • 7.4.3. France
      • 7.4.3.1. By Component
    • 7.4.4. Spain
      • 7.4.4.1. By Component
    • 7.4.5. Italy
      • 7.4.5.1. By Component
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Component
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Component

8. Asia Pacific Adaptive Deep Brain Stimulation Systems Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Component
    • 8.1.1. Implantable Pulse Generator (IPG)
    • 8.1.2. DBS Leads & Extensions
    • 8.1.3. Accessories & Ancillary Components
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Parkinson's Disease
    • 8.2.2. Epilepsy
    • 8.2.3. Essential Tremor
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Component
    • 8.4.2. Australia
      • 8.4.2.1. By Component
    • 8.4.3. China
      • 8.4.3.1. By Component
    • 8.4.4. India
      • 8.4.4.1. By Component
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Component
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Component

9. Latin America Adaptive Deep Brain Stimulation Systems Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Component
    • 9.1.1. Implantable Pulse Generator (IPG)
    • 9.1.2. DBS Leads & Extensions
    • 9.1.3. Accessories & Ancillary Components
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Parkinson's Disease
    • 9.2.2. Epilepsy
    • 9.2.3. Essential Tremor
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Component
    • 9.4.2. Mexico
      • 9.4.2.1. By Component
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Component

10. Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Component
    • 10.1.1. Implantable Pulse Generator (IPG)
    • 10.1.2. DBS Leads & Extensions
    • 10.1.3. Accessories & Ancillary Components
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Parkinson's Disease
    • 10.2.2. Epilepsy
    • 10.2.3. Essential Tremor
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
      • 10.4.1.1. By Component
    • 10.4.2. South Africa
      • 10.4.2.1. By Component
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Component

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
    • 11.2.2. Newronika S.p.A.
    • 11.2.3. The Regents of The University of California
    • 11.2.4. Stanford University
    • 11.2.5. University of Toronto
    • 11.2.6. University of Florida Health

List of Tables

  • Table 1: Global Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 2: Global Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 3: Global Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 4: Global Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 6: North America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 7: North America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 8: North America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: U.S. Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 10: Canada Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 11: Europe Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 12: Europe Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 13: Europe Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 14: Europe Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 15: Germany Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 16: U.K. Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 17: France Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 18: Italy Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 19: Spain Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 20: Scandinavia Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 21: Rest of Europe Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 22: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 23: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 24: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 25: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: China Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 27: Japan Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 28: India Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 29: Australia Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 30: Southeast Asia Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 31: Rest of Asia Pacific Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 32: Latin America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 33: Latin America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 34: Latin America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 35: Latin America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Brazil Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 37: Mexico Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 38: Rest of Latin America Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 39: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 40: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 43: GCC Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 44: South Africa Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034
  • Table 45: Rest of Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Revenue (USD million) Forecast, by Component, 2021-2034

List of Figures

  • Figure 1: Global Adaptive Deep Brain Stimulation Systems Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Component, 2025 & 2034
  • Figure 3: Global Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Adaptive Deep Brain Stimulation Systems Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Component, 2025 & 2034
  • Figure 7: North America Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Component, 2025
  • Figure 8: North America Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Application, 2025 & 2034
  • Figure 9: North America Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Application, 2025
  • Figure 10: North America Adaptive Deep Brain Stimulation Systems Market Value (USD million), by End User, 2025 & 2034
  • Figure 11: North America Adaptive Deep Brain Stimulation Systems Market Value Share (%), by End User, 2025
  • Figure 12: North America Adaptive Deep Brain Stimulation Systems Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Adaptive Deep Brain Stimulation Systems Market Value Share (%), By Country, 2025
  • Figure 14: Europe Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Component, 2025 & 2034
  • Figure 15: Europe Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Component, 2025
  • Figure 16: Europe Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Application, 2025 & 2034
  • Figure 17: Europe Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Application, 2025
  • Figure 18: Europe Adaptive Deep Brain Stimulation Systems Market Value (USD million), by End User, 2025 & 2034
  • Figure 19: Europe Adaptive Deep Brain Stimulation Systems Market Value Share (%), by End User, 2025
  • Figure 20: Europe Adaptive Deep Brain Stimulation Systems Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Adaptive Deep Brain Stimulation Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Component, 2025 & 2034
  • Figure 23: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Component, 2025
  • Figure 24: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Value (USD million), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Adaptive Deep Brain Stimulation Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Component, 2025 & 2034
  • Figure 31: Latin America Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Component, 2025
  • Figure 32: Latin America Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Application, 2025 & 2034
  • Figure 33: Latin America Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Adaptive Deep Brain Stimulation Systems Market Value (USD million), by End User, 2025 & 2034
  • Figure 35: Latin America Adaptive Deep Brain Stimulation Systems Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Adaptive Deep Brain Stimulation Systems Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Adaptive Deep Brain Stimulation Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Component, 2025 & 2034
  • Figure 39: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Component, 2025
  • Figure 40: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Value (USD million), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Value (USD million), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Adaptive Deep Brain Stimulation Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Adaptive Deep Brain Stimulation Systems Market Share (%), By Company, 2025